N Scott Fine - Net Worth and Insider Trading
N Scott Fine Net Worth
The estimated net worth of N Scott Fine is at least $599,943 dollars as of 2024-05-26. N Scott Fine is the CEO of Cyclo Therapeutics Inc and owns about 444,402 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $599,943. Details can be seen in N Scott Fine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that N Scott Fine has not made any transactions after 2023-04-20 and currently still holds the listed stock(s).
Transaction Summary of N Scott Fine
N Scott Fine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, N Scott Fine owns 2 companies in total, including Cyclo Therapeutics Inc (CYTH) , and Forward Industries Inc (FORD) .
Click here to see the complete history of N Scott Fine’s form 4 insider trades.
Insider Ownership Summary of N Scott Fine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | director |
| FORD | Forward Industries Inc | 2015-02-23 | director |
N Scott Fine Latest Holdings Summary
N Scott Fine currently owns a total of 1 stock. N Scott Fine owns 444,402 shares of Cyclo Therapeutics Inc (CYTH) as of April 20, 2023, with a value of $599,943.
Latest Holdings of N Scott Fine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | 444,402 | 1.35 | 599,943 |
Holding Weightings of N Scott Fine
N Scott Fine Form 4 Trading Tracker
According to the SEC Form 4 filings, N Scott Fine has made a total of 9 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 299,402 shares on April 20, 2023, which cost N Scott Fine around $212,575.
Insider Trading History of N Scott Fine
- 1
N Scott Fine Trading Performance
GuruFocus tracks the stock performance after each of N Scott Fine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by N Scott Fine is -6.3%. GuruFocus also compares N Scott Fine's trading performance to market benchmark return within the same time period. The performance of stocks bought by N Scott Fine within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how N Scott Fine's insider trading performs compared to the benchmark.
Performance of N Scott Fine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.46 | | | | | |
| Relative Return to S&P 500(%) | 0.66 | | | | | |
N Scott Fine Ownership Network
N Scott Fine Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
N Scott Fine is the director of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, N Scott Fine made 1 insider transaction in Cyclo Therapeutics Inc (CYTH) with a net purchase of 299,402. Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 59,881 shares made by Markus Sieger , and a net purchase of 59,881 shares made by Francis Patrick Ostronic .
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
N Scott Fine Mailing Address
Above is the net worth, insider trading, and ownership report for N Scott Fine. You might contact N Scott Fine via mailing address: 600 3rd Ave, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
